Long-term changes of choroidal blood flow velocity in Vogt-Koyanagi-Harada disease.
Shinya AbeTomoko NakamuraErika OkumuraToshihiko OiwakeAnnabelle A OkadaAtsushi HayashiPublished in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2022)
With initiation of corticosteroid treatment in VKH disease patients, choroidal blood flow improved and was maintained for 2 years. However, the presence of SGF should be taken into consideration when interpreting MBR results in VKH disease patients.